Individuals with measured HbA1c outcomes were randomly divided into a 60:40 ratio between the development (31,346 individuals) and validation (20,865 individuals) groups to build the one-year glycemic response therapy selection model
3.8 GLP-1 in sepsis: Friend or foe
In addition, CGM metrics associated with the AGP (mean glucose, glucose management indicator, glycemic variability, time-in-range, etc.) are included, allowing people living with diabetes and their healthcare professionals to act on the data that the AGP provides
In the STEP 1 trial, once weekly GLP-1 agonist at 2.4 mg with lifestyle intervention led to a mean body weight reduction of 14.9 percent at 68 weeks, compared with 2.4 percent with placebo 2
So, they weaved in something so you cant get it
The lettuce provides the vehicle without the caloric cost, leaving room for more protein